C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 409/14 (2006.01) A61K 31/4439 (2006.01) A61P 9/00 (2006.01)
Patent
CA 2591117
The invention is concerned with novel heteroarylacetamides of formula (I) Rd- C(O)-N(Re)-Rc-CH2-C(O)-N(Ra)(Rb), wherein Ra to Re are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.
L'invention concerne des hétéroarylacétamides de formule (I) : Rd-C(O)-N(Re)-Rc-CH2-C(O)-N(Ra)(Rb) (I), dans laquelle Ra à Re sont tels que définis dans la description et les revendications, ainsi que des sels acceptables sur le plan physiologique de ceux-ci. Ces composés inhibent le facteur de coagulation Xa et peuvent être utilisés comme médicaments.
Boehringer Markus
Groebke Zbinden Katrin
Haap Wolfgang
Hilpert Hans
Panday Narendra
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Novel heteroarylacetamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel heteroarylacetamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel heteroarylacetamides will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2012083